Raghavendra Appalla #1675363
Fairleigh Dickinson University
EPS 8109_8P
Abstract
In this paper the importance of free medication is explained clearly in this paper.In this paper the various aspects like intellectual property,finance drug development and the development on framework for essential drugs distribution.In this paper all the above aspects are analyzed and then these are supported with an example regarding Malasiya’s case study with the affordability,cost,availability and pricing of drugs.A new set of ideas and proposals have been discussed thorughly which would lead to the availability of drugs in huge amounts with the contribution …show more content…
This states that even though the drugs are available with the pharamecitucal industries to provide with free medication they are not willing to provide as they believe that by doing so in such manner they felt that it would be a violation of intellectual property and would seriously be taken into action. If there was certain relaxation on such type of issues then perhaps many people would have been saved from the epidemic despite they all fell as a prey to this deadly disease. The other step to provide free nedication would be classification of drug categories into a separate category called the essential drugs.
“The position of pharmaceutical industry in a highly competitive global market has turned drugs from public health tool to a commodity”( Dyann Wirth,2002,pg.5)this has widely effected the world health conditions and need for now is to make the drugs which are life saving as essential drugs.For the drugs to be classified in such manner the should be combined efforts from the pharmaceutical companies and also the governing …show more content…
References
Trouiller, P., Torreele, E., & Foster, S. (2002). Drugs for neglected diseases: A failure of the market and a public health failure? Tropical Medicine &International Health, 6(11), 4-4.
Singh, H., Creese, A., & Foster, S. (2007). Evaluating Drug Prices, Availability, Affordability, and Price Components: Implications for Access to Drugs in Malaysia. PLOS Medicine, 4(3), 1,3-1,3.
Henry, D., & Lexchin, J. (16 Novembe). The pharmaceutical industry as a medicines provider (Vol. 360, pp. 1590-1595). Retrieved from http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(02)11527-3/fulltext.
Trouille, P. (Jan 27 ). Access to Essential Drugs in Poor Countries A Lost Battle? (4th ed., Vol. 281, pp. 1590-1595). Retrieved from